Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Nov 08 04:00PM ET
6.20
Dollar change
+0.17
Percentage change
2.82
%
Index- P/E- EPS (ttm)-2.15 Insider Own- Shs Outstand32.85M Perf Week1.31%
Market Cap228.41M Forward P/E- EPS next Y-2.04 Insider Trans- Shs Float- Perf Month26.37%
Income-70.85M PEG- EPS next Q-0.45 Inst Own2.94% Short Float- Perf Quarter2.48%
Sales6.80M P/S33.59 EPS this Y4.32% Inst Trans- Short Ratio1.98 Perf Half Y64.67%
Book/sh4.96 P/B1.25 EPS next Y-1.94% ROA-33.64% Short Interest0.03M Perf Year38.08%
Cash/sh4.62 P/C1.34 EPS next 5Y- ROE-37.39% 52W Range3.32 - 12.70 Perf YTD48.33%
Dividend Est.- P/FCF- EPS past 5Y-3.32% ROI-42.60% 52W High-51.18% Beta1.02
Dividend TTM- Quick Ratio14.33 Sales past 5Y342.86% Gross Margin- 52W Low86.75% ATR (14)0.57
Dividend Ex-Date- Current Ratio14.33 EPS Y/Y TTM-11.27% Oper. Margin-1050.74% RSI (14)55.07 Volatility6.78% 8.81%
Employees182 Debt/Eq0.02 Sales Y/Y TTM-27.94% Profit Margin-1042.67% Recom1.80 Target Price10.12
Option/ShortNo / Yes LT Debt/Eq0.01 EPS Q/Q-44.66% Payout- Rel Volume0.51 Prev Close6.03
Sales Surprise93.64% EPS Surprise10.48% Sales Q/Q-72.67% EarningsOct 31 AMC Avg Volume16.90K Price6.20
SMA206.35% SMA5012.81% SMA20020.03% Trades Volume8,692 Change2.82%
Date Action Analyst Rating Change Price Target Change
Aug-30-22Downgrade RBC Capital Mkts Outperform → Sector Perform
Aug-29-22Downgrade SVB Leerink Outperform → Mkt Perform $30 → $8
May-25-22Upgrade Credit Suisse Underperform → Neutral
Apr-27-22Downgrade Credit Suisse Neutral → Underperform
Jul-13-21Initiated Cowen Outperform $50
Jul-12-21Resumed SVB Leerink Outperform $36
Nov-07-24 04:00PM
Nov-05-24 04:00PM
Oct-31-24 04:00PM
Oct-25-24 01:00AM
Oct-23-24 09:29AM
01:00AM Loading…
Oct-22-24 01:00AM
01:00AM
Oct-04-24 01:00AM
Sep-27-24 01:00AM
Aug-26-24 04:00PM
Jul-14-24 12:16PM
Jun-24-24 07:16AM
Jun-20-24 07:28AM
Jun-17-24 01:00AM
Jun-14-24 07:30AM
01:00AM Loading…
01:00AM
Jun-12-24 07:46AM
Jun-11-24 01:00AM
Jun-01-24 08:00AM
May-16-24 04:00PM
Apr-29-24 11:00AM
Apr-19-24 11:12AM
Apr-17-24 11:12AM
Mar-26-24 09:26AM
Mar-14-24 04:00PM
Mar-01-24 04:00PM
Jan-07-24 04:00PM
Jan-05-24 04:00PM
Dec-14-23 01:00AM
Dec-10-23 12:00PM
01:00AM Loading…
Nov-14-23 01:00AM
Nov-03-23 12:00PM
Nov-02-23 02:00AM
Nov-01-23 02:00AM
Oct-26-23 04:00PM
Sep-13-23 01:00AM
Aug-24-23 04:00PM
Jul-13-23 08:06AM
Jun-27-23 01:00AM
Jun-19-23 12:00PM
Jun-02-23 08:59AM
May-25-23 05:01PM
May-16-23 04:00PM
May-13-23 02:00AM
May-11-23 04:00PM
Apr-18-23 01:44AM
Apr-14-23 01:00AM
Apr-04-23 11:44AM
Mar-13-23 09:30AM
12:22AM
Mar-11-23 02:14AM
Mar-09-23 04:00PM
Mar-02-23 04:00PM
Feb-28-23 01:15AM
Feb-10-23 01:00AM
Jan-16-23 01:00AM
Jan-12-23 06:18AM
Jan-08-23 03:00PM
Dec-30-22 01:00AM
Dec-12-22 07:00PM
Dec-01-22 11:46PM
Nov-10-22 01:00AM
Nov-04-22 09:39AM
Nov-03-22 12:30PM
Nov-02-22 12:30PM
Oct-27-22 04:00PM
04:00PM
Aug-25-22 04:30PM
Aug-18-22 01:00AM
Jul-21-22 11:30AM
Jun-10-22 01:00AM
May-12-22 04:05PM
May-11-22 01:00AM
May-03-22 12:00PM
Apr-27-22 08:02AM
06:01AM
05:59AM
Apr-26-22 04:05PM
02:00PM
Apr-23-22 01:00AM
Apr-13-22 12:00PM
09:00AM
Mar-24-22 02:00AM
Mar-17-22 01:00AM
Mar-15-22 04:30PM
Feb-25-22 04:30PM
Feb-11-22 04:10PM
Feb-10-22 07:13AM
01:00AM
Jan-28-22 05:57AM
Jan-23-22 02:28AM
Jan-18-22 01:00AM
Jan-13-22 05:00PM
Jan-12-22 10:13AM
Jan-11-22 11:37AM
Jan-10-22 06:51PM
09:32AM
08:58AM
07:31AM
07:13AM
Molecular Partners AG engages in the development of protein therapies for treatment of serious diseases like cancer and sight-threatening disorders. It also develops its products through its brand known as DARPins, which targets specific and potent monoclonal antibodies that offers potential to address existing limitations of antibody drugs. The company products include Abicipar, MP0250/MP0274 and Clinical Trials. The company was founded by Christian Zahnd, Patrick Amstutz, Patrik Forrer, Andreas Pluckthun, and Michael Tobias Stumpp on November 22, 2004 and is headquartered in Schlieren, Switzerland.